Ars Pharmaceuticals Inc (SPRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 89,149 | 30 | 1,316 | 5,506 | 0 |
| Cost of Goods | 977 | N/A | N/A | N/A | N/A |
| Gross Profit | 88,172 | 30 | 1,316 | 5,506 | N/A |
| Operating Expenses | 92,232 | 67,550 | 36,832 | 24,960 | 32,918 |
| Operating Income | -3,083 | -67,520 | -35,516 | -19,454 | -32,918 |
| Other Income | 11,369 | 13,155 | 834 | -789 | -29 |
| Pre-tax Income | 8,286 | -54,365 | -34,682 | -20,243 | -32,947 |
| Income Tax | 288 | N/A | N/A | N/A | N/A |
| Net Income Continuous | 7,998 | -54,365 | -34,682 | -20,243 | -32,947 |
| Net Income | $7,998 | $-54,365 | $-34,682 | $-20,243 | $-32,947 |
| EPS Basic Total Ops | 0.08 | -0.57 | -0.87 | -0.70 | -11.33 |
| EPS Basic Continuous Ops | 0.08 | -0.57 | -0.87 | -0.70 | -11.33 |
| EPS Diluted Total Ops | 0.08 | -0.57 | -0.87 | -0.70 | -11.33 |
| EPS Diluted Continuous Ops | 0.08 | -0.57 | -0.87 | -0.70 | -11.33 |
| EPS Diluted Before Non-Recurring Items | 0.08 | -0.57 | -0.87 | -2.56 | -11.33 |
| EBITDA(a) | $-10,258 | $-74,295 | $-35,197 | $-19,241 | $-32,250 |